![]() |
市場調查報告書
商品編碼
2065233
數位外科技術市場預測至2034年-全球分析(按組件、產品類型、技術、應用、最終用戶和地區分類)Digital Surgery Technologies Market Forecasts to 2034 - Global Analysis By Component (Hardware, Software, and Services), Product Type, Technology, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,全球數位外科技術市場預計將在 2026 年達到 61 億美元,到 2034 年達到 174 億美元,在預測期內以 13.9% 的複合年成長率成長。
數位外科技術是指由軟體、硬體和資料平台組成的整合生態系統,旨在透過利用人工智慧、機器人技術、擴增實境(AR) 和先進的視覺化工具,提高手術精度、規劃、培訓和治療效果。這些解決方案使外科醫生能夠更精確地了解解剖細節,從而規劃複雜的手術;在機器人輔助下進行手術;並在手術過程中獲得即時指導。透過手術工作流程的數位化和性能數據的收集,這些技術支援持續改進,減少手術差異,並在廣泛的外科領域提升病患安全。
對微創手術和機器人輔助手術的需求激增。
微創手術的優點——出血量少、住院時間短、恢復快、併發症發生率低——使其在患者和臨床醫生中越來越受歡迎。數位化手術平台,特別是配備觸覺回饋和防手震的機器人系統,使外科醫生能夠透過更小的切口完成複雜的手術,同時保持高度的靈活性和視野。全球手術數量的不斷成長,以及透過模擬訓練提高的數位化工具使用熟練度,正在加速各個專科(包括泌尿系統、婦科和整形外科)從傳統開放性手術向數位化輔助微創手術的轉變。
資本投資大,總擁有成本高
實施數位化手術平台需要大量的初始資本投入,涵蓋機器人系統、影像基礎設施以及與現有醫院IT環境的整合。除了初始投資外,持續的成本,例如維護合約、軟體許可費、器械更換和專業人員培訓,都會導致高昂的總擁有成本(TCO)。這種經濟負擔是農村醫院和低收入地區醫療保健系統面臨的主要障礙。預算限制以及需要證明其相對於傳統手術方法的可衡量投資回報率(ROI)仍然限制著數位化手術平台的普及,尤其是在提供三級醫療服務的大學醫院之外。
利用外科資料科學和人工智慧擴展術中導航功能
數位平台收集的結構化手術數據量日益成長,推動了人工智慧模型的發展,這些模型能夠提供即時術中指導、預測併發症風險並評估手術效果。手術資料科學平台聚合影片、手術器械運動學和生理指標等多模態數據,為外科醫師和醫院系統提供可操作的洞察。隨著雲端基礎設施的成熟和資料標準化框架的出現,利用不同醫療機構的多樣化手術資料集訓練人工智慧的潛力顯著提升,為開發下一代自主導航系統和個人化手術指導工具創造了機會。
互聯手術平台中的網路安全漏洞
隨著數位化手術平台與醫院網路、雲端系統和外部資料儲存庫的連接日益緊密,網路安全風險也日益凸顯。手術過程中,惡意干擾手術機器人或影像系統可能創造危及生命的後果,使醫療機構成為複雜網路攻擊的主要目標。此外,在聯網系統中儲存和傳輸高度敏感的患者手術資料也存在資料外洩和隱私侵犯的風險。隨著監管機構加強對連網醫療設備安全性的審查,製造商面臨日益沉重的合規負擔,並可能因其平台內建的網路安全措施不足而承擔法律責任。
新冠疫情對數位外科技術市場造成了顯著的短期衝擊,擇期手術被廣泛推遲,現有機器人和影像平台的使用量也隨之下降。由於醫院優先保障重症監護室容量和應對疫情,投資決策也被推遲。然而,這場危機也凸顯了遠端手術規劃、虛擬訓練環境以及人工智慧驅動的手術流程指導在減少對現場操作的需求方面的戰略價值。隨著疫情後擇期手術的恢復,醫院加快了對技術現代化的投資,為疫情後全球醫療系統逐步採用數位外科平台奠定了基礎。
在預測期內,硬體領域預計將佔據最大的市場佔有率。
預計在預測期內,硬體部分將佔據最大的市場佔有率。這主要得益於手術機器人、高解析度成像系統、感測器和追蹤設備在實現數位化手術中發揮的關鍵作用。這些物理系統相關的巨額資本投資,以及醫療機構不斷擴展機器人手術計畫所帶來的高額更換和升級需求,預計將確保硬體收入的持續成長。隨著新的機器人平台獲得FDA批准,以及醫院擴大採用電腦輔助手術,硬體部分預計仍將是市場中最大的組成部分。
預計人工智慧和機器學習領域在預測期內將呈現最高的複合年成長率。
在預測期內,人工智慧和機器學習領域預計將呈現最高的成長率。人工智慧在數位外科手術中的應用涵蓋術前影像分析、術中導航、治療結果預測和術後併發症監測,使其成為外科生態系統中最具通用性和擴充性的技術。領先的醫療設備和軟體公司對外科人工智慧研究的策略性投資,以及用於模型訓練的標註手術資料集的日益豐富,正在加速這些技術的成熟。人工智慧驅動的即時手術決策支援的潛力正吸引著來自創業投資和整個行業企業研發部門的濃厚興趣。
在預測期內,北美預計將佔據最大的市場佔有率。這得歸功於北美地區聚集了許多領先的手術機器人公司、世界一流的學術醫療中心推動的臨床研究,以及日益完善的機器人輔助手術保險報銷政策。大量的手術量、患者對微創治療的高度認可以及充足的醫療資本預算,都促進了這項技術的快速普及。此外,美國食品藥物管理局(FDA)對新型外科醫療設備的嚴格監管流程,也為製造商提供了清晰的框架,幫助其將下一代數位手術平台商業化。
在預測期內,亞太地區預計將呈現最高的複合年成長率。快速的都市化、不斷壯大的中產階級及其對醫療保健日益成長的期望,以及政府對醫院基礎設施現代化建設的大力投資,都在推動市場需求。中國、韓國、日本和印度等國家在機器人手術平台和人工智慧手術器械的應用方面取得了顯著進展。中國和韓國本土手術機器人製造商的崛起進一步活性化了市場活動。東南亞地區醫療旅遊的蓬勃發展也促使各國加大對先進手術能力的投資,以吸引海外病患。
According to Stratistics MRC, the Global Digital Surgery Technologies Market is accounted for $6.1 billion in 2026 and is expected to reach $17.4 billion by 2034, growing at a CAGR of 13.9% during the forecast period. Digital Surgery Technologies represent an integrated ecosystem of software, hardware, and data platforms designed to augment surgical precision, planning, training, and outcomes through the application of artificial intelligence, robotics, augmented reality, and advanced visualization tools. These solutions enable surgeons to plan complex procedures with greater anatomical detail, execute operations with robotic assistance, and receive real-time intraoperative guidance. By digitizing surgical workflows and capturing performance data, these technologies support continuous improvement, reduce procedural variability, and enhance patient safety across a wide spectrum of surgical disciplines.
Surging demand for minimally invasive procedures and robotic-assisted surgery
Patients and clinicians alike are increasingly favoring minimally invasive surgical approaches owing to their association with reduced blood loss, shorter hospital stays, faster recovery, and lower complication rates. Digital surgery platforms, particularly robotic systems with haptic feedback and tremor filtration, enable surgeons to perform intricate procedures through smaller incisions with greater dexterity and visualization. Rising surgical volumes globally, coupled with growing surgeon familiarity with digital tools acquired through simulation training, are accelerating the transition from open to digitally assisted minimally invasive surgery across specialties including urology, gynecology, and orthopedics.
Substantial capital investment requirements and high total cost of ownership
The deployment of digital surgery platforms requires significant upfront capital expenditure covering robotic systems, imaging infrastructure, and integration with existing hospital IT environments. Beyond initial acquisition, ongoing costs including maintenance contracts, software licensing fees, instrument replacement, and specialized staff training contribute to an elevated total cost of ownership. For community hospitals and healthcare systems in lower-income regions, these financial commitments present formidable barriers. Budget constraints and the need to demonstrate measurable return on investment relative to conventional surgical methods continue to temper adoption rates, particularly outside tertiary academic medical centers.
Expansion of surgical data science and AI-driven intraoperative guidance
The growing volume of structured surgical data captured by digital platforms is enabling the development of AI models capable of providing real-time intraoperative guidance, predicting complication risks, and benchmarking surgical performance. Surgical data science platforms aggregate multi-modal data including video, instrument kinematics, and physiological metrics to generate actionable insights for individual surgeons and hospital systems. As cloud infrastructure matures and data standardization frameworks emerge, the potential to train AI on diverse surgical datasets across institutions grows substantially, creating opportunities for next-generation autonomous guidance systems and personalized surgical coaching tools.
Cybersecurity vulnerabilities in connected surgical platforms
The increasing connectivity of digital surgery platforms with hospital networks, cloud systems, and external data repositories introduces significant cybersecurity risks. Malicious interference with surgical robots or imaging systems during a procedure could have life-threatening consequences, making healthcare facilities attractive targets for sophisticated cyberattacks. Furthermore, the storage and transmission of sensitive patient surgical data across networked systems creates exposure to data breaches and privacy violations. As regulatory bodies heighten scrutiny on connected medical device security, manufacturers face escalating compliance burdens and potential liabilities associated with inadequate cybersecurity protections embedded within their platforms.
COVID-19 caused significant short-term disruption to the digital surgery technologies market as elective surgical procedures were broadly postponed, reducing utilization of installed robotic and imaging platforms. Capital expenditure decisions were deferred as hospitals prioritized ICU capacity and pandemic response. However, the crisis simultaneously underscored the strategic value of remote surgical planning, virtual training environments, and AI-assisted procedural guidance in reducing physical presence requirements. As elective volumes recovered post-pandemic, hospitals accelerated technology modernization investments, positioning digital surgery platforms for accelerated post-crisis adoption across global healthcare systems.
The Hardware segment is expected to be the largest during the forecast period
The Hardware segment is expected to account for the largest market share during the forecast period, underpinned by the critical role of surgical robots, high-definition imaging systems, sensors, and tracking devices in enabling digitally augmented procedures. The substantial capital cost of these physical systems, combined with high replacement and upgrade demand from health systems expanding their robotic surgery programs, ensures sustained hardware revenue. As newer robotic platforms achieve broader FDA clearance and hospital adoption of computer-assisted surgery grows, the hardware segment will continue to represent the largest market component.
The AI & Machine Learning segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the AI & Machine Learning segment is predicted to witness the highest growth rate. AI applications in digital surgery span preoperative imaging analysis, intraoperative guidance, outcome prediction, and postoperative complication monitoring, making this technology the most cross-functional and scalable within the surgical ecosystem. Strategic investments by leading medical device and software companies in surgical AI research, combined with growing availability of annotated surgical datasets for model training, are accelerating capability maturation. The prospect of real-time AI-driven surgical decision support is drawing significant venture capital and corporate R&D interest across the sector.
During the forecast period, the North America region is expected to hold the largest market share, supported by its concentration of pioneering surgical robotics companies, world-class academic medical centers driving clinical research, and a reimbursement environment increasingly supportive of robotic-assisted procedures. High surgical procedure volumes, strong patient awareness of minimally invasive options, and substantial healthcare capital budgets enable rapid technology adoption. Additionally, robust regulatory pathways administered by the FDA for novel surgical devices provide manufacturers with clear frameworks to commercialize next-generation digital surgery platforms.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, rapid urbanization, growing middle-class populations with rising healthcare expectations, and aggressive government investment in hospital infrastructure modernization are driving demand. Countries including China, South Korea, Japan, and India are significantly expanding their adoption of robotic surgery platforms and AI-based surgical tools. The establishment of domestic surgical robotics manufacturers in China and South Korea is further intensifying market activity. Growing medical tourism across Southeast Asia also stimulates investment in advanced surgical capabilities to attract international patients.
Key players in the market
Some of the key players in Global Digital Surgery Technologies Market include Intuitive Surgical, Medtronic plc, Stryker Corporation, Johnson & Johnson, Siemens Healthineers, Zimmer Biomet, Smith+Nephew, Olympus Corporation, Brainlab AG, Karl Storz SE & Co. KG, GE HealthCare, Caresyntax, Asensus Surgical, CMR Surgical, and Proximie.
In February 2026, Intuitive Surgical announced the commercial availability of its da Vinci 5 robotic surgical system in additional international markets following successful launches in North America and Europe. The next-generation platform incorporates enhanced force feedback capabilities, advanced instrument articulation, and integrated AI-assisted imaging, enabling surgeons to perform a broader range of complex minimally invasive procedures with improved tactile awareness and precision.
In March 2026, Johnson & Johnson MedTech announced a strategic partnership with Caresyntax to integrate its surgical data science platform with the OTTAVA robotic surgical system. This collaboration aims to leverage real-time intraoperative analytics and AI-powered workflow optimization tools to enhance surgical outcomes, standardize procedural protocols, and accelerate performance benchmarking across hospital networks deploying the combined technology solution.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.